Menu

Sweden Cancels Agreement With Elsevier Over Open Access

A consortium of institutions will not renew its contract with the publisher that ends in June, following the lead of organizations in other countries.

May 16, 2018
Ashley Yeager

WIKIMEDIA, MARCUS HANSSONA collection of Swedish universities and research institutions will not renew its current contract with Elsevier that expires at the end of June, Times Higher Education reports today (May 16). The move comes not long after academic institutions in other countries have let publishers’ subscriptions lapse when fee negotiations come to an impasse.

See “French Universities Cancel Subscriptions to Springer Journals

“The current system for scholarly communication must change, and our only option is to cancel deals when they don’t meet our demands for a sustainable transition to open access,” Astrid Söderbergh Widding, president of Stockholm University and chair of the consortium, tells OpenAccess.se, a blog published by the National Library of Sweden.

According to the blog, the Bibsam Consortium, representing 85 higher education and research institutions in the country, had requested that Elsevier allow researchers at the institutions to publish their work in open access formats and receive reading access to all of the publisher’s journal articles. The consortium also wanted the publisher to commit to a pricing structure that would encourage the move to open access.

In 2017, the consortium’s members spent €12 million ($14.2 million USD) on licensing fees for researchers to read Elsevier content and another €1.3 million ($1.5 million USD) was spent on article-processing charges, OpenAccess.se reports, noting that Swedish researchers publish around 4,000 articles per year in Elsevier journals.

After the contract ends next month, researchers will have access to articles published between 1995 and 2017 but nothing published after June 30, 2018. The consortium has advised researchers interested in studies published after the contract termination date to “search for open-access versions of papers, to contact authors directly for a copy, or to consider an inter-library loan,” according to Times Higher Education.

Other countries, however, have been more successful in creating open-access agreements. Most recently, the Netherlands created subscriptions that combine publishing and reading access into a single fee.

See “Dutch Universities, Journal Publishers Agree on Open-Access Deals

 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.